FTO抑制通过降低ferroptosis激活剂ACSL4和益纤维素因子TGFBI的调节来减轻纤维化

Dalin Zhang1, Chun-Lung Chiu1,2, Ru Wen1

  • 1Department of Urology, Stanford University School of Medicine, Stanford, CA 94305, USA.

iScience
|October 6, 2025
PubMed
概括

向FTO酶可以减少纤维化和铁亡,为由损伤引起的慢性病 (CKD) 提供新的治疗策略.